載入...
AXL receptor tyrosine kinase as a therapeutic target in NSCLC
The AXL receptor tyrosine kinase and its ligand, Gas6, regulate key processes in lung cancer growth, metastasis, and epithelial–mesenchymal transition-associated drug resistance. Gas6 and AXL expression have been correlated with poor prognosis and advanced clinical stage in patients with lung cancer...
Na minha lista:
| 發表在: | Lung Cancer (Auckl) |
|---|---|
| Main Authors: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Dove Medical Press
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5217513/ https://ncbi.nlm.nih.gov/pubmed/28210148 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/LCTT.S60438 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|